Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena Pharma says EU is reviewing weight loss drug
Yahoo/AP
Monday, March 26, 2012 - 12:42pm
tags:
Arena, lorcaserin, Europe, obesity
Obesity Drugs May Need Heart Risk Studies Before Approval
Bloomberg
Monday, March 26, 2012 - 12:22pm
tags:
obesity, Vivus, Arena Pharmaceuticals, Orexigen, Qnexa
VIVUS Announces Acceptance of Avanafil Application in Europe
Yahoo
Monday, March 26, 2012 - 12:20pm
tags:
Vivus, Avanafil, Europe, erectile dysfunction
Monthly shots of Amgen drug slash cholesterol up to 66 pct
Reuters
Monday, March 26, 2012 - 12:19pm
tags:
Amgen, AMG145, PCSK9 inhibitor
Opportunity On The Horizon For Discovery Laboratories Investors
Seeking Alpha
Monday, March 26, 2012 - 12:17pm
tags:
Discovery Labs
Roche extends Illumina offer until late April
Reuters
Monday, March 26, 2012 - 12:16pm
tags:
Roche, M&A, tender offer, Illumina
Prolor Biotech's Phase II Initiation Has Profound Pipeline Implications
Seeking Alpha
Monday, March 26, 2012 - 12:16pm
tags:
Prolor, hGH-CTP
Regeneron cholesterol drug faces sudden challenge
Reuters
Monday, March 26, 2012 - 12:10pm
tags:
Amgen, Regeneron, PCSK9 inhibitor, AMG145, REGN727, Sanofi
Bare shelves in docs' sample closets as pharma overhauls sales
Fierce Pharma
Monday, March 26, 2012 - 11:15am
tags:
physicians, samples, drug reps
Teva announces FDA approval of QNASL
Yahoo/Fly on the Wall
Monday, March 26, 2012 - 11:14am
tags:
FDA, QNASL, Teva Pharmaceuticals
Pfizer - A Grand Opportunity
Seeking Alpha
Monday, March 26, 2012 - 11:11am
tags:
Pfizer
J&J Drug Treats Lung Clots With Less Bleeding, Study Finds
Bloomberg
Monday, March 26, 2012 - 11:10am
tags:
JNJ, lung clots, Bayer, Xarelto, bloodthinners
AstraZeneca: U.S. Court denies preliminary injunction application against FDA
Yahoo/Fly on the Wall
Monday, March 26, 2012 - 11:09am
tags:
FDA, AstraZeneca, Quetiapine, generics, Seroquel XR
Teva Pharma to raise debt outside the U.S
Chicago Tibune, IL
Sunday, March 25, 2012 - 12:41pm
tags:
Teva Pharmaceuticals
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
Pipeline Review
Sunday, March 25, 2012 - 12:39pm
tags:
Synthon Pharmaceuticals, trastuzumab, Herceptin, breast cancer, gastric cancer, biosimilars, Genentech
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sunday, March 25, 2012 - 11:38am
tags:
Achillion, Amylin, Ariad Pharmaceuticals, Aveo Pharmaceutical, Cell Therapeutics, EXACT Sciences, Idenix, Exelixis, Halozyme, Lexicon Pharmaceuticals, Nektar, Momenta, ONYX Pharmaceuticals, Optimer Pharmaceuticals, PDL Biopharma, Questcor Pharmaceuticals, Santarus, Spectrum Pharmaceuticals, Regeneron, Vivus
OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters
Pharmalive
Saturday, March 24, 2012 - 1:20pm
tags:
OncoGenex
Front-Month Put Volume Rises on MAP Pharmaceuticals
Schaeffer's Research
Saturday, March 24, 2012 - 1:19pm
tags:
MAP Pharmaceuticals
Shanghai Fosun Pharmaceutical Group takes significant stake in Simcere; Nephron to build plant in SC
FiercePharma
Saturday, March 24, 2012 - 1:16pm
tags:
Simcere, Fosun Pharmaceutical
Sandoz recalls morphine after packaging error (in Canada)
Globe and Mail, Canada
Saturday, March 24, 2012 - 1:14pm
tags:
Sandoz, recalls

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.